Eriko Sumi - Institute for Advancement of Clinical and Translational Science (iACT), Kyoto University Hospital

基本信息

浏览量：41

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 44 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Figure S1-S7, Table S1-S5 from CDK9 Inhibitor FIT-039 Suppresses Viral Oncogenes E6 and E7 and Has a Therapeutic Effect on HPV-Induced Neoplasia

Masahiko Ajiro, Hiroyuki Sakai,Hiroshi Onogi,Makoto Yamamoto,Eriko Sumi, Teruo Sawada, Takashi Nomura,Kenji Kabashima, Takamitsu Hosoya,Masatoshi Hagiwara

openalex（2023）

引用0浏览0引用

Supplementary Figure Legends (figure S1-S7) from CDK9 Inhibitor FIT-039 Suppresses Viral Oncogenes E6 and E7 and Has a Therapeutic Effect on HPV-Induced Neoplasia

Masahiko Ajiro, Hiroyuki Sakai,Hiroshi Onogi, Makoto Yamamoto,Eriko Sumi,Teruo Sawada, Takashi Nomura, Kenji Kabashima, Takamitsu Hosoya, Masatoshi Hagiwara

crossref（2023）

引用0浏览0引用

245 Development and application of physiologically based pharmacokinetic – pharmacodynamic (PBPK-PD) model for dose optimization of TAK-102: GPC3 targeted CAR-T armored with IL-7 and CCL-19

Yasutoshi Kuboki,Takako Eguchi Nakajima,Takafumi Koyama,Eriko Sumi, Kotaro Suzuki, Agnish Dey,Hideaki Kagehara, Petar Pop-Damkov, Eiki Maeda,Takenori Akaike, Kondala Atkuri, Masashi Ochi,Ganesh M Mugundu,Aman Singh

Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)

引用0浏览0引用

Safety of the Cyclin Dependent Kinase 9 (CDK9) Inhibitor FIT039 for Cervical Intraepithelial Neoplasia (CIN) 1 or 2 in a Phase I/II Trial

Junzo Hamanishi,Eriko Sumi, Taito Miyamoto,Ryuji Uozumi,Koji Yamanoi,Harue Tada,Yoko Amino,Yu Hidaka,Masayo Ukita,Ken Yamaguchi,Ryuta Asada,Masahiko Ajiro,Teruo Sawada,Masatoshi Hagiwara,Masaki Mandai

Journal of clinical oncologyno. 16_suppl (2022): 3022-3022

引用1浏览0引用

Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial

Takashi Nomura,Eriko Sumi,Gyohei Egawa,Saeko Nakajima,Eiko Toichi,Nana Inoue, Mami Shibuya, Natsuko Okamoto,Tsuyoshi Mitsuishi,Ryuji Uozumi,Harue Tada,Takayuki Nakagawa,Nobuhiro Kusuba,Aika Okuno,Chihiro Shimizuhira, Makiko Ishikawa,Shiro Tanaka,Masatoshi Hagiwara,Kenji Kabashima

JID innovationsno. 3 (2021): 100026-100026

引用0浏览0WOS引用

Medical Development Efforts at the iACT

Eriko Sumi

Proceedings for Annual Meeting of The Japanese Pharmacological Societyno. 0 (2021): 3-S31

引用0浏览0引用

Survivin-responsive Conditionally Replicating Adenovirus for Patients with Advanced Sarcoma Demonstrated Potent and Long-Term Efficacy and High Safety in a Phase I Clinical Trial

Satoshi Nagano,Toshitaka Futagawa,Eriko Sumi,Nobuhiro Ijichi,Munekazu Yamaguchi,Masanori Nakajo,Teruto Hashiguchi,Yasuo Takeda,Takashi Yoshiura,Akira Shimizu,Muneo Takatani,Setsuro Komiya,Ken-ichiro Kosai

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用0浏览0引用

Acceleration of TR from basic science to clinical trial at the iACT

Eriko Sumi

Proceedings for Annual Meeting of The Japanese Pharmacological Societyno. 0 (2020)

引用0浏览0引用

A Qualitative Study on the Differences Between Trial Populations and the Approved Therapeutic Indications of Antineoplastic Agents by 3 Regulatory Agencies From 2010 to 2018

Eriko Sumi,Ryuta Asada,Ying Lu,Toshiko Ito-Ihara,Kevin Grimes

CLINICAL THERAPEUTICS（2020）

引用3浏览0WOS引用

Clinical Trial to Evaluate the Therapeutic Benefits of Limbal-Supported Contact Lens Wear for Ocular Sequelae Due to Stevens-Johnson Syndrome/toxic Epidermal Necrolysis

Motohiro Itoi,Mayumi Ueta,Ken Ogino,Eriko Sumi,Kojiro Imai,Satoshi Teramukai,Shigeru Kinoshita,Chie Sotozono

Contact Lens and Anterior Eye（2020）

引用8浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn